Zydus introduces cancer treatment IBYRA in India, making advanced therapy accessible
In a groundbreaking development for cancer treatment in India, Zydus Lifesciences has launched Olaparib under the brand name IBYRA, a pioneering PARP inhibitor designed to ... Read More
Torrent Pharmaceuticals to co-market Saroglitazar Mg with Zydus for liver health
Torrent Pharmaceuticals Limited and Zydus Lifesciences Limited announced a significant licensing and supply agreement to co-market Saroglitazar Mg, a drug for treating Non-Alcoholic Steato Hepatitis ... Read More
FDA approves ZITUVIMET by Zydus Lifesciences for Type 2 diabetes treatment
Zydus Lifesciences Limited has achieved a significant milestone with the U.S. Food and Drug Administration (FDA) granting approval for ZITUVIMET, a combination of Sitagliptin and ... Read More
Zydus and Lupin forge alliance for NAFLD and NASH treatment in India
In a significant move within the pharmaceutical industry, Zydus Lifesciences Limited, renowned for its global lifesciences innovations, and Lupin Limited, a leading global pharma entity, ... Read More
FDA approves Zydus Lifesciences’ ZITUVIO tablets for Type 2 diabetes
Zydus Lifesciences Limited announced today that the U.S. Food and Drug Administration (FDA) has granted approval for its New Drug Application (NDA) for ZITUVIO (Sitagliptin) ... Read More
Zydus Lifesciences announces Punit Patel as new CEO for Americas operations
Global lifesciences firm, Zydus Lifesciences Limited, recently declared the appointment of Punit Patel as the President and Chief Executive Officer for its Americas wing. He's ... Read More
Zydus Lifesciences gets FDA final approval for Varenicline Tablets
Zydus Lifesciences has been granted final approval from the US Food and Drug Administration (FDA) to manufacture and market Varenicline Tablets, 0.5 mg and 1 ... Read More
Zydus Lifesciences to commercialize OncoStem’s CanAssist Breast test
Zydus Lifesciences has secured exclusive marketing rights to CanAssist Breast, a prognostic test for breast cancer patients in the early stages, from Bengaluru-based OncoStem. According ... Read More
Zydus Lifesciences launches diabetes drugs Sitaglyn and Siglyn in India
Zydus Lifesciences (Cadila Healthcare) has rolled out the molecule Sitagliptin in India under the Sitaglyn and Siglyn brand names for the treatment of Type 2 ... Read More
Cadila Healthcare bags order for 1cr ZyCoV-D vaccines from Indian govt
Cadila Healthcare (Zydus Cadila) has bagged an order from the Indian government to deliver one crore doses of its ZyCoV-D Plasmid DNA Covid-19 vaccine. According ... Read More